Pacific Biosciences of California, Inc. Cost, Amortization
Pacific Biosciences of California, Inc. (PACB) reported Cost, Amortization of $183.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSoldAmortization · last filed 2026-08-06
- Pacific Biosciences of California, Inc. cost, amortization for the quarter ending 2026-06-30 was $183.00K, a 0.00% change year-over-year.
- Pacific Biosciences of California, Inc. cost, amortization for the quarter ending 2026-03-31 was $183.00K, a 95.79% decline year-over-year.
- Pacific Biosciences of California, Inc. cost, amortization for the quarter ending 2025-12-31 was $183.00K, a 91.76% decline year-over-year.
- Pacific Biosciences of California, Inc. cost, amortization for the quarter ending 2025-09-30 was $183.00K, a 94.28% decline year-over-year.
- Pacific Biosciences of California, Inc. cost, amortization for fiscal 2025 was $4.89M, a 47.90% decline from fiscal 2024.
- Pacific Biosciences of California, Inc. cost, amortization for fiscal 2024 was $9.39M, a 373.68% increase from fiscal 2023.
- Pacific Biosciences of California, Inc. cost, amortization for fiscal 2023 was $1.98M, a 170.53% increase from fiscal 2022.
- Pacific Biosciences of California, Inc. cost, amortization for fiscal 2022 was $733.00K, a 139.54% increase from fiscal 2021.
| Period end | Cost, Amortization 3 month | Cost, Amortization 6 month | Cost, Amortization 9 month | Cost, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $183.00K 10-Q · filed 2026-08-06 | $366.00K 10-Q · filed 2026-08-06 | $549.00K derived: sum of 3 quarters · filed 2026-08-06 | $732.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $183.00K 10-Q · filed 2026-05-08 | $366.00K derived: sum of 2 quarters · filed 2026-05-08 | $549.00K derived: sum of 3 quarters · filed 2026-05-08 | $732.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $183.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $366.00K derived: sum of 2 quarters · filed 2026-02-25 | $549.00K derived: sum of 3 quarters · filed 2026-08-06 | $4.89M 10-K · filed 2026-02-25 |
| 2025-09-30 | $183.00K 10-Q · filed 2025-11-06 | $366.00K derived: sum of 2 quarters · filed 2026-08-06 | $4.71M 10-Q · filed 2025-11-06 | $6.93M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $183.00K 10-Q · filed 2026-08-06 | $4.53M 10-Q · filed 2026-08-06 | $6.75M derived: sum of 3 quarters · filed 2026-08-06 | $9.95M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $4.34M 10-Q · filed 2026-05-08 | $6.57M derived: sum of 2 quarters · filed 2026-05-08 | $9.77M derived: sum of 3 quarters · filed 2026-05-08 | $12.39M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $2.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $5.42M derived: sum of 2 quarters · filed 2026-02-25 | $8.05M derived: sum of 3 quarters · filed 2026-02-25 | $9.39M 10-K · filed 2026-02-25 |
| 2024-09-30 | $3.20M 10-Q · filed 2025-11-06 | $5.83M derived: sum of 2 quarters · filed 2025-11-06 | $7.17M 10-Q · filed 2025-11-06 | $8.61M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $2.63M 10-Q · filed 2025-08-07 | $3.97M 10-Q · filed 2025-08-07 | $5.40M derived: sum of 3 quarters · filed 2026-02-25 | $5.59M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $1.34M 10-Q · filed 2025-05-12 | $2.78M derived: sum of 2 quarters · filed 2026-02-25 | $2.96M derived: sum of 3 quarters · filed 2026-02-25 | $3.14M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.62M derived: sum of 2 quarters · filed 2026-02-25 | $1.80M derived: sum of 3 quarters · filed 2026-02-25 | $1.98M 10-K · filed 2026-02-25 |
| 2023-09-30 | $184.00K 10-Q · filed 2024-11-12 | $367.00K derived: sum of 2 quarters · filed 2024-11-12 | $550.00K 10-Q · filed 2024-11-12 | $733.00K derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $183.00K 10-Q · filed 2024-08-09 | $366.00K 10-Q · filed 2024-08-09 | $549.00K derived: sum of 3 quarters · filed 2025-03-17 | $733.00K derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $183.00K 10-Q · filed 2024-05-09 | $366.00K derived: sum of 2 quarters · filed 2025-03-17 | $550.00K derived: sum of 3 quarters · filed 2025-03-17 | $733.00K derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $183.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $367.00K derived: sum of 2 quarters · filed 2025-03-17 | $550.00K derived: sum of 3 quarters · filed 2025-03-17 | $733.00K 10-K · filed 2025-03-17 |
| 2022-09-30 | $184.00K 10-Q · filed 2022-11-08 | $367.00K derived: sum of 2 quarters · filed 2023-08-04 | $550.00K 10-Q · filed 2022-11-08 | $733.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $183.00K 10-Q · filed 2023-08-04 | $366.00K 10-Q · filed 2023-08-04 | $549.00K derived: sum of 3 quarters · filed 2024-02-28 | $672.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $183.00K 10-Q · filed 2023-05-04 | $366.00K derived: sum of 2 quarters · filed 2024-02-28 | $489.00K derived: sum of 3 quarters · filed 2024-02-28 | |
| 2021-12-31 | $183.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $306.00K derived: sum of 2 quarters · filed 2024-02-28 | $306.00K 10-K · filed 2024-02-28 | |
| 2021-09-30 | $123.00K 10-Q · filed 2022-11-08 | $123.00K 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |